A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

Overview of attention for article published in Journal of Translational Medicine, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 948 followers.

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma https://t.co/ri6sde7Eup https://t.co/UUzDbtW3NJ

New article: A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma https://t.co/GghXNEEYR2 #lungcancer #oncology https://t.co/dJunXFa625

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.